FdaApplication
NDA 205029
Identifiers
- fda_app_no: NDA205029
Properties
| Property | Value |
|---|---|
| applicant_name | BPI LABS LLC |
| application_type | NDA |
| approval_date | 2014-07-29 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
| EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS |
| EPINEPHRINE | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| EPINEPHRINE | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
5 products